Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.

Garvie PA, Brummel SS, Allison SM, Malee KM, Mellins CA, Wilkins ML, Harris LL, Patton ED, Chernoff MC, Rutstein RM, Paul ME, Nichols SL; Pediatric HIV/AIDS Cohort Study.

Pediatr Infect Dis J. 2017 Aug;36(8):751-757. doi: 10.1097/INF.0000000000001573.


Strategies parents use to give children oral medicine: a qualitative study of online discussion forums.

Bergene EH, Rø TB, Steinsbekk A.

Scand J Prim Health Care. 2017 Jun;35(2):221-228. doi: 10.1080/02813432.2017.1333308. Epub 2017 Jun 5.


Prevalence of, and barriers to the disclosure of HIV status to infected children and adolescents in a district of Ghana.

Gyamfi E, Okyere P, Enoch A, Appiah-Brempong E.

BMC Int Health Hum Rights. 2017 Apr 8;17(1):8. doi: 10.1186/s12914-017-0114-6.


Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.

Nebot Giralt A, Nöstlinger C, Lee J, Salami O, Lallemant M, Ouma O, Nyamongo I, Marchal B.

BMJ Open. 2017 Mar 29;7(3):e014528. doi: 10.1136/bmjopen-2016-014528.


Disclosure of their HIV status to perinatally infected youth using the adapted Blasini disclosure model in Haiti and the Dominican Republic: preliminary results.

Beck-Sagué CM, Dévieux J, Pinzón-Iregui MC, Lerebours-Nadal L, Abreu-Pérez R, Bertrand R, Rouzier V, Gaston S, Ibanez G, Halpern M, Pape JW, Dorceus P, Preston SM, Dean AG, Nicholas SW, Blasini I.

AIDS. 2015 Jun;29 Suppl 1:S91-8. doi: 10.1097/QAD.0000000000000665.


Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers' views.

Santer M, Ring N, Yardley L, Geraghty AW, Wyke S.

BMC Pediatr. 2014 Mar 4;14:63. doi: 10.1186/1471-2431-14-63. Review.


A cross-sectional study of disclosure of HIV status to children and adolescents in western Kenya.

Vreeman RC, Scanlon ML, Mwangi A, Turissini M, Ayaya SO, Tenge C, Nyandiko WM.

PLoS One. 2014 Jan 27;9(1):e86616. doi: 10.1371/journal.pone.0086616. eCollection 2014.


Disclosure of HIV status to children in resource-limited settings: a systematic review.

Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM.

J Int AIDS Soc. 2013 May 27;16:18466. doi: 10.7448/IAS.16.1.18466. Review.


Family group psychotherapy to support the disclosure of HIV status to children and adolescents.

Nicastro E, Continisio GI, Storace C, Bruzzese E, Mango C, Liguoro I, Guarino A, Officioso A.

AIDS Patient Care STDS. 2013 Jun;27(6):363-9. doi: 10.1089/apc.2012.0465. Epub 2013 May 21.


Prevalence, perceptions, and correlates of pediatric HIV disclosure in an HIV treatment program in Kenya.

John-Stewart GC, Wariua G, Beima-Sofie KM, Richardson BA, Farquhar C, Maleche-Obimbo E, Mbori-Ngacha D, Wamalwa D.

AIDS Care. 2013;25(9):1067-76. doi: 10.1080/09540121.2012.749333. Epub 2012 Dec 20.


Disclosure of their HIV status to infected children: a review of the literature.

Pinzón-Iregui MC, Beck-Sagué CM, Malow RM.

J Trop Pediatr. 2013 Apr;59(2):84-9. doi: 10.1093/tropej/fms052. Epub 2012 Oct 15. Review.


Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study.

Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F.

AIDS Patient Care STDS. 2011 Oct;25(10):611-21. doi: 10.1089/apc.2011.0083. Epub 2011 Aug 8.


Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

AIDS Patient Care STDS. 2011 Mar;25(3):191-200. doi: 10.1089/apc.2010.0181. Epub 2011 Feb 16.


The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting.

Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS.

AIDS Patient Care STDS. 2010 Oct;24(10):639-49. doi: 10.1089/apc.2010.0079.


Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Rakhmanina NY, van den Anker JN, Soldin SJ, van Schaik RH, Mordwinkin N, Neely MN.

Ther Drug Monit. 2010 Jun;32(3):273-81. doi: 10.1097/FTD.0b013e3181dca14b.


We never thought this would happen: transitioning care of adolescents with perinatally acquired HIV infection from pediatrics to internal medicine.

Vijayan T, Benin AL, Wagner K, Romano S, Andiman WA.

AIDS Care. 2009 Oct;21(10):1222-9. doi: 10.1080/09540120902730054.


Pediatric adherence to HIV antiretroviral therapy.

Haberer J, Mellins C.

Curr HIV/AIDS Rep. 2009 Nov;6(4):194-200. Review.


The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

J Pediatr Psychol. 2009 Mar;34(2):164-75. doi: 10.1093/jpepsy/jsn068. Epub 2008 Jul 22.


Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications.

Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, Bettica L, Tepper VJ, Abrams EJ.

AIDS Patient Care STDS. 2008 Aug;22(8):637-47. doi: 10.1089/apc.2007.0110.


Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.

Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S.

Pediatrics. 2007 Jun;119(6):e1371-83. Epub 2007 May 28. Review.

Supplemental Content

Support Center